Upgrade to SI Premium - Free Trial

FDA accepts Axsome drug application for cataplexy treatment

July 15, 2026 7:00 AM
Axsome Therapeutics (NASDAQ: AXSM) announced that the U.S. Food and Drug Administration has accepted for filing the company's New Drug ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA